LEAP THERAPEUTICS INC - COM (LPTX)

CUSIP: 52187K101

Q4 2022 13F Holders as of 31 Dec 2022

Share change
-3,852,861
Put/Call ratio
38%
SEC-reported price per share
$0.45
Number of holders
59
Value change
-$4,282,992
Number of buys
22
Open additional details 1 more signal available
Number of sells
29

Security key

52187K101

Report period

Q4 2022

Institutions

59

Top holders

10

Ownership snapshot

Top reported holders of LPTX - LEAP THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BeOne Medicines Ltd.
Disclosed value leader
BeOne Medicines Ltd.
Comparable rows
0/15
Latest evidence
30 Sep 2022
3/4/5 13F Highest disclosed value: $20,943,045 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BeOne Medicines Ltd. has the largest disclosed position value at $20.94M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BeOne Medicines Ltd.'s linked filing trail.
Disclosed position value Top 5
BeOne Medicines Ltd. $20.94M
PERCEPTIVE ADVISORS LLC $6.58M
Artal Group S.A. $3.52M
Rock Springs Capital Management LP $3.22M
VANGUARD GROUP INC $2.87M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BeOne Medicines Ltd.
3/4/5
10%+ Owner
—
denominator unverified
$20,943,045
7,348,437 shares
— 24 Sep 2021
PERCEPTIVE ADVISORS LLC
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$6,575,000
7,472,148 shares
— 30 Sep 2022
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$3,520,000
4,000,000 shares
— 30 Sep 2022
Rock Springs Capital Management LP
13F
Company
13F
—
denominator unverified
$3,221,000
3,659,847 shares
— 30 Sep 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$2,872,000
3,264,171 shares
— 30 Sep 2022
M28 Capital Management LP
13F
Company
13F
—
denominator unverified
$2,345,000
2,664,400 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
59
Shares
32,949,031
Rows available
59
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
66
Q4 2022 holders
59
Holder diff
-7
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .